Lvm Capital Management LTD Abbott Laboratories Transaction History

Lvm Capital Management LTD

$869 Million
Q3 2024

A detailed history of Lvm Capital Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Lvm Capital Management LTD holds 33,184 shares of ABT stock, worth $3.85 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

33,184

Previous 33,184 -0.0%

Holding current value

$3.85 Million

Previous $3.45 Million 9.72%

% of portfolio

0.44%

Previous 0.39%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$100.73 - $112.44 $21,757 - $24,287	-216 Reduced 0.65%	33,184 $3.45 Million
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $8,214 - $9,072	75 Added 0.23%	33,400 $3.8 Million
Q4 2023 Jan 12, 2024	BUY	$90.19 - $110.4 $360,399 - $441,158	3,996 Added 13.62%	33,325 $3.67 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $14,329 - $17,193	-150 Reduced 0.51%	29,329 $2.84 Million
Q2 2023 Jul 07, 2023	SELL	$100.78 - $112.29 $19,450 - $21,671	-193 Reduced 0.65%	29,479 $3.21 Million
Q1 2023 Apr 17, 2023	BUY	$96.86 - $114.01 $77,488 - $91,208	800 Added 2.77%	29,672 $3 Million
Q4 2022 Jan 03, 2023	SELL	$95.06 - $111.52 $133,084 - $156,128	-1,400 Reduced 4.62%	28,872 $3.17 Million
Q3 2022 Oct 05, 2022	BUY	$96.76 - $112.03 $122,014 - $141,269	1,261 Added 4.35%	30,272 $2.93 Million
Q1 2022 Apr 13, 2022	BUY	$114.02 - $139.04 $25,768 - $31,423	226 Added 0.79%	29,011 $3.43 Million
Q4 2021 Jan 04, 2022	SELL	$115.53 - $141.46 $25,994 - $31,828	-225 Reduced 0.78%	28,785 $4.05 Million
Q3 2021 Oct 05, 2021	SELL	$116.66 - $129.06 $4,899 - $5,420	-42 Reduced 0.14%	29,010 $3.43 Million
Q2 2021 Jul 08, 2021	SELL	$105.79 - $124.53 $10,579 - $12,453	-100 Reduced 0.34%	29,052 $3.37 Million
Q1 2021 Apr 06, 2021	SELL	$108.84 - $128.23 $22,312 - $26,287	-205 Reduced 0.7%	29,152 $3.49 Million
Q4 2020 Jan 11, 2021	SELL	$105.0 - $114.42 $117,915 - $128,493	-1,123 Reduced 3.68%	29,357 $3.21 Million
Q3 2020 Oct 05, 2020	SELL	$91.64 - $111.29 $15,212 - $18,474	-166 Reduced 0.54%	30,480 $3.32 Million
Q2 2020 Jul 13, 2020	SELL	$76.57 - $98.0 $13,782 - $17,640	-180 Reduced 0.58%	30,646 $2.8 Million
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $25,123 - $27,968	-320 Reduced 1.03%	30,826 $2.68 Million
Q2 2019 Jul 02, 2019	BUY	$72.88 - $85.0 $27,184 - $31,705	373 Added 1.21%	31,146 $0
Q1 2019 Apr 05, 2019	SELL	$66.22 - $80.06 $8,409 - $10,167	-127 Reduced 0.41%	30,773 $0
Q4 2018 Jan 14, 2019	SELL	$65.56 - $74.27 $6,818 - $7,724	-104 Reduced 0.34%	30,900 $2.23 Million
Q3 2018 Oct 05, 2018	SELL	$60.81 - $73.36 $21,283 - $25,676	-350 Reduced 1.12%	31,004 $0
Q2 2018 Jul 10, 2018	BUY	$57.57 - $63.54 $25,561 - $28,211	444 Added 1.44%	31,354 $0
Q1 2018 Apr 16, 2018	SELL	$56.27 - $63.62 $30,948 - $34,991	-550 Reduced 1.75%	30,910 $0
Q4 2017 Jan 11, 2018	SELL	$53.68 - $57.47 $37,576 - $40,229	-700 Reduced 2.18%	31,460 $0
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $1.55 Million - $1.73 Million	32,160	32,160 $0

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvm Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lvm Capital Management LTD with notifications on news.

Account

Lvm Capital Management LTD Abbott Laboratories Transaction History